Evidence Synthesis
Vasuprada witnessed a significant improvement in its gross margin, accelerating to 79.94%, up from -1.53%.
Evidence Synthesis
Last synthesized: 4 Sept 2026, 15:15
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
Vasuprada witnessed a significant improvement in its gross margin, accelerating to 79.94%, up from -1.53%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 79.94 % | -1.53 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -1.53 % | -2.68 | ▲ |
| REVENUE_GROWTH_YOY | 16.3 % | — | - |
| PRICE_CHANGE_PERCENT | 0 % | — | - |
| DAILY_VOLUME | 1 shares | 136 | ▼ |
| CLOSE_PRICE | 106.95 INR | 106.95 | - |